SEARCH News

Please select news category and type keyword(s) to search

COVID-19: Empat Kluster Baharu, Kes Aktif Meningkat 196

Oleh Melati Mohd Ariff



Berikut adalah rangkuman TERKINI mingguan mengenai COVID-19 dan perkara yang berkaitan di Malaysia serta di peringkat dunia dari 8 Ogos hingga pukul 7:30 mlm 14 Ogos.



Jumlah kes COVID-19 di Malaysia melepasi angka 9,000 sementara di peringkat global, kes wabak ini mengatasi 20 juta dengan lebih 700,000 kematian. Lebih 14 juta orang pesakit COVID-19 dilaporkan sembuh. Pandemik COVID-19 sudah merebak ke lebih 200 buah negara dan wilayah.



KUALA LUMPUR (Bernama) -- Kes baharu COVID-19 sepanjang rangkuman mingguan ini banyak melibatkan kes import iaitu kes jangkitan di luar negara di samping empat kluster baharu iaitu Kurau (Pulau Pinang), Meranti (Wilayah Persekutuan Kuala Lumpur), Tawar (Kedah) dan terkini Muda (Kedah).



Daripada 20 kes baharu dilaporkan sehingga pukul 12.00 tengah hari Jumaat 14 Ogos, 13 kes adalah penularan dalam negara melibatkan warganegara Malaysia, iaitu Kluster Tawar Kedah (10 kes), Kluster Tawar Pulau Pinang (1 kes), Kluster Muda Kedah (1 kes) dan satu kes SARI (Jangkitan Pernafasan Akut Teruk).



Tujuh lagi adalah kes import (jangkitan di luar negara) , iaitu enam (6) melibatkan warganegara pulang dari Lubnan (3 kes), masing-masing satu dari Taiwan , Indonesia dan Yaman, sementara seorang bukan warganegara di Sarawak yang pulang dari Yaman.



COVID-19: Empat Kluster Baharu, Kes Aktif Meningkat 196

Oleh Melati Mohd Ariff



Berikut adalah rangkuman TERKINI mingguan mengenai COVID-19 dan perkara yang berkaitan di Malaysia serta di peringkat dunia dari 8 Ogos hingga pukul 7:30 mlm 14 Ogos.



Jumlah kes COVID-19 di Malaysia melepasi angka 9,000 sementara di peringkat global, kes wabak ini mengatasi 20 juta dengan lebih 700,000 kematian. Lebih 14 juta orang pesakit COVID-19 dilaporkan sembuh. Pandemik COVID-19 sudah merebak ke lebih 200 buah negara dan wilayah.



KUALA LUMPUR (Bernama) -- Kes baharu COVID-19 sepanjang rangkuman mingguan ini banyak melibatkan kes import iaitu kes jangkitan di luar negara di samping empat kluster baharu iaitu Kurau (Pulau Pinang), Meranti (Wilayah Persekutuan Kuala Lumpur), Tawar (Kedah) dan terkini Muda (Kedah).



Daripada 20 kes baharu dilaporkan sehingga pukul 12.00 tengah hari Jumaat 14 Ogos, 13 kes adalah penularan dalam negara melibatkan warganegara Malaysia, iaitu Kluster Tawar Kedah (10 kes), Kluster Tawar Pulau Pinang (1 kes), Kluster Muda Kedah (1 kes) dan satu kes SARI (Jangkitan Pernafasan Akut Teruk).



Tujuh lagi adalah kes import (jangkitan di luar negara) , iaitu enam (6) melibatkan warganegara pulang dari Lubnan (3 kes), masing-masing satu dari Taiwan , Indonesia dan Yaman, sementara seorang bukan warganegara di Sarawak yang pulang dari Yaman.



UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad



KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.



ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.



Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.



UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad



KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.



ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.



Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.



UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad



KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.



ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.



Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.



Embracing New Norms To Safeguard Against Pandemic

By Erda Khursyiah Basir



This article is in conjunction with the launch of the Embracing New Norms campaign by Prime Minister Tan Sri Muhyiddin Yassin in Pagoh, Johor, today.



KUALA LUMPUR (Bernama) – With the end of the COVID-19 pandemic nowhere in sight, the best thing for Malaysians to do to keep themselves safe is to mask up and carry a sanitiser with them when going out, in addition to washing hands regularly and observing physical distancing.



Most of them have been taking these precautions since the Movement Control Order (MCO) was enforced on March 18 to break the chain of COVID-19 infections.



While the public, in general, has been adapting to the new norms, certain quarters are still throwing caution to the wind, which is why the government, beginning Aug 1, decided to make it compulsory for everyone to wear a face mask when travelling in public transport and in congested public places.



Embracing New Norms To Safeguard Against Pandemic

By Erda Khursyiah Basir



This article is in conjunction with the launch of the Embracing New Norms campaign by Prime Minister Tan Sri Muhyiddin Yassin in Pagoh, Johor, today.



KUALA LUMPUR (Bernama) – With the end of the COVID-19 pandemic nowhere in sight, the best thing for Malaysians to do to keep themselves safe is to mask up and carry a sanitiser with them when going out, in addition to washing hands regularly and observing physical distancing.



Most of them have been taking these precautions since the Movement Control Order (MCO) was enforced on March 18 to break the chain of COVID-19 infections.



While the public, in general, has been adapting to the new norms, certain quarters are still throwing caution to the wind, which is why the government, beginning Aug 1, decided to make it compulsory for everyone to wear a face mask when travelling in public transport and in congested public places.



Embracing New Norms To Safeguard Against Pandemic

By Erda Khursyiah Basir



This article is in conjunction with the launch of the Embracing New Norms campaign by Prime Minister Tan Sri Muhyiddin Yassin in Pagoh, Johor, today.



KUALA LUMPUR (Bernama) – With the end of the COVID-19 pandemic nowhere in sight, the best thing for Malaysians to do to keep themselves safe is to mask up and carry a sanitiser with them when going out, in addition to washing hands regularly and observing physical distancing.



Most of them have been taking these precautions since the Movement Control Order (MCO) was enforced on March 18 to break the chain of COVID-19 infections.



While the public, in general, has been adapting to the new norms, certain quarters are still throwing caution to the wind, which is why the government, beginning Aug 1, decided to make it compulsory for everyone to wear a face mask when travelling in public transport and in congested public places.



COVID-19: Kluster Sivagangga Semakin Mengganas

Oleh Melati Mohd Ariff



Berikut adalah rangkuman TERKINI mingguan mengenai COVID-19 dan perkara yang berkaitan di Malaysia serta di peringkat dunia dari 1 Ogos hingga pukul 7:30 mlm 7 Ogos.



 Jumlah kes COVID-19 di Malaysia melepasi angka 9,000 sementara di peringkat global, kes wabak ini mengatasi 19 juta dengan lebih 700,000 kematian. Sekitar 12 juta orang pesakit COVID-19 dilaporkan sembuh. Pandemik COVID-19 sudah merebak ke lebih 200 buah negara dan wilayah.



 KUALA LUMPUR (Bernama) -- Kes penularan tempatan sepanjang rangkuman minggu ini didominasi Kluster PUI (Pesakit Bawah Siasatan) Sivagangga yang pertama kali dilaporkan oleh Kementerian Kesihatan Malaysia (KKM) pada 28 Julai lepas.



Daripada 16 kes penularan tempatan yang dilaporkan sehingga pukul 12 tengah hari ini, 12 kes adalah daripada Kluster PUI Sivagangga, iaitu 10 kes di Perlis, satu (1) kes di Kedah dan satu (1) kes di Pulau Pinang.



Menurut Ketua Pengarah Kesihatan, Datuk Noor Hisham Abdullah dalam satu kenyataan, setakat ini Kluster PUI Sivagangga mencatat 43 kes positif COVID-19.



COVID-19: Kluster Sivagangga Semakin Mengganas

Oleh Melati Mohd Ariff



Berikut adalah rangkuman TERKINI mingguan mengenai COVID-19 dan perkara yang berkaitan di Malaysia serta di peringkat dunia dari 1 Ogos hingga pukul 7:30 mlm 7 Ogos.



 Jumlah kes COVID-19 di Malaysia melepasi angka 9,000 sementara di peringkat global, kes wabak ini mengatasi 19 juta dengan lebih 700,000 kematian. Sekitar 12 juta orang pesakit COVID-19 dilaporkan sembuh. Pandemik COVID-19 sudah merebak ke lebih 200 buah negara dan wilayah.



 KUALA LUMPUR (Bernama) -- Kes penularan tempatan sepanjang rangkuman minggu ini didominasi Kluster PUI (Pesakit Bawah Siasatan) Sivagangga yang pertama kali dilaporkan oleh Kementerian Kesihatan Malaysia (KKM) pada 28 Julai lepas.



Daripada 16 kes penularan tempatan yang dilaporkan sehingga pukul 12 tengah hari ini, 12 kes adalah daripada Kluster PUI Sivagangga, iaitu 10 kes di Perlis, satu (1) kes di Kedah dan satu (1) kes di Pulau Pinang.



Menurut Ketua Pengarah Kesihatan, Datuk Noor Hisham Abdullah dalam satu kenyataan, setakat ini Kluster PUI Sivagangga mencatat 43 kes positif COVID-19.





HealthEdge


EXCLUSIVE

UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad

KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.

ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.

Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.

read more ››

IN FOCUS

UMSC: Pain Management


In Focus : UMSC Raya Open House 2018

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 1

In Focus : UMSC - Fatty Liver, The Silent Epidemic Part 2